Table 1.
Report* | Ref | Risk of bias |
Applicability concerns |
||||||
---|---|---|---|---|---|---|---|---|---|
Domain I Patient selection |
Domain II Index test |
Domain III Reference standard |
Domain IV Flow & timing |
Domain I Patient selection |
Domain II Index test |
Domain III Reference standard | |||
Jendrny et al. (2020) | [46] | ||||||||
Grandjean et al. (2020) | [47] | ||||||||
Eskandari et al. (2021) | [48] | −DTE 1 | |||||||
−DTE 2 | |||||||||
Grandjean et al. (2021) | [49] | ||||||||
Essler et al. (2021) | [50] | −DTE 1 | |||||||
−DTE 2 | |||||||||
−DTE 3 | |||||||||
−DTE 4 | |||||||||
−DTE 5 | |||||||||
−DTE 6 | |||||||||
−DTE 7 | |||||||||
−DTE 8 | |||||||||
Hag-Ali et al. (2021) | [39] | ||||||||
Mendel et al. (2021) | [51] | −DTE 1 | |||||||
−DTE 2 | |||||||||
−DTE 3 | |||||||||
Angeletti et al. (2021) | [52] | ||||||||
Sarkis et al. (2022) | [53] | ||||||||
Vlachová et al. (2021) (pre) | [54] | ||||||||
Jendrny et al. (2021) | [55] | −DTE 1 | |||||||
−DTE 2 | |||||||||
−DTE 3 | |||||||||
−DTE 4 | |||||||||
−DTE 5 | |||||||||
Wurtz et al. (2021) (pre)† | [41] | () | () | () | () | () | () | () | |
Vesga et al. (2021) | [40] | −DTE 1 | |||||||
−DTE 2 | |||||||||
−DTE 3 | |||||||||
−DTE 4 | |||||||||
Maia et al. (2021) | [56] | ||||||||
ten Hagen et al. (2021) | [57] | −DTE 1 | |||||||
−DTE 2 | |||||||||
−DTE 3 | |||||||||
Grandjean et al. (2022) | [58] | ||||||||
Grandjean et al. (2022) | [59] | ||||||||
Devillier et al. (2022) | [60] | −DTE 1 | |||||||
−DTE 2 | |||||||||
Chaber et al. (2022) | [61] | ||||||||
Guest et al. (2022) | [62] | −DTE 1‡ | |||||||
−DTE 2‡ | |||||||||
−DTE 3 | |||||||||
Mancilla-Tapia et al. (2022) | [63] | −DTE 1 | |||||||
−DTE 2 | |||||||||
Maurer et al. (2022) | [44] | −DTE 1 | |||||||
−DTE 2§ | () | ||||||||
Kantele et al. (2022) | [43] | −DTE 1 | |||||||
−DTE 2§ | () | ||||||||
Grandjean et al. (2022) | [42] | ||||||||
Twele et al. (2022) | [64] | −DTE 1 | |||||||
−DTE 2 | |||||||||
−DTE 3 | |||||||||
ten Hagen et al. (2022) | [45] | −DTE 1§ | () | ||||||
−DTE 2§ | () | ||||||||
−DTE 3§ | () | ||||||||
−DTE 4§ | () | ||||||||
Demirbas et al. (2023) | [65] | −DTE 1 | |||||||
−DTE 2 | |||||||||
−DTE 3 |
DTE = diagnostic test evaluation; Pre = preprint; Ref = reference.
low risk or concerns; high risk or concerns; unclear risk or concerns.
*Reports sorted by publication date. †Not enough information for appropriate assessment. ‡DTE described in appendix. §DTE was conducted with cross-sectional patient selection and study design. However, additional samples had to be added to the study process due to low prevalence.